Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
Louise B. Grochow(Johns Hopkins University), O. Michael Colvin(Dartmouth College), Robert B. Brundrett, Richard J. Jones(Sidney Kimmel Cancer Center), Rein Saral(University of Maryland, Baltimore), George W. Santos(Johns Hopkins University), Tian-Ling Chen, Hayden G. Braine(Johns Hopkins University)
Cited by 406
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
|New England Journal of Medicine|1991|947
VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION
|Transplantation|1987|914
Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
|New England Journal of Medicine|1983|818
Cytotoxic T Cells in Cytomegalovirus Infection
|New England Journal of Medicine|1982|596